To date, related studies have found abnormal expression of miR‐34a in a variety of tumors and cell lines, including neuroblastoma, lung cancer, and melanoma cell lines.20, 21, 22, 23 We found that Axl was a potential target of miR‐34a using Target Scan bioinformatics software, and further double luciferase reporter gene assays revealed that Axl was targeted by miR‐34a. This evidence concerns the gene AXL and neuroblastoma.